Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.6.2851

Metaplastic Breast Carcinoma: a Heterogeneous Disease  

Gultekin, Melis (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Eren, Gulnihan (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Babacan, Taner (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Yildiz, Ferah (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Altundag, Kadri (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Guler, Nilufer (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Ozisik, Yavuz (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Yazici, Gozde (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Hurmuz, Pervin (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Gurkaynak, Murat (Department of Radiation Oncology, Faculty of Medicine, Hacettepe University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.6, 2014 , pp. 2851-2856 More about this Journal
Abstract
The aim of this study is to evaluate clinicopathologic characteristics and the multi-disciplinary treatment results of metaplastic breast cancer (MBC) patients treated in a single institute. Seventeen female patients with MBC treated in our department between June 2000 and January 2012 were identified and retrospectively evaluated. The median age at diagnosis was 46 years (range, 26-66 years). The median tumor size at diagnosis was 3.5 cm (range 1.5-12 cm). Six (35%) patients underwent breast conservation surgery and 11 (65%) mastectomy. Axillary lymph node metastasis was found in 6 (35%) patients. Twelve (71%) had triple negative tumors. Postoperative RT and systemic adjuvant treatment was given to all patients accordingly to stage and biological characteristics. Median follow-up time was 27 months (range, 12-151 months). At the time of this analysis, 14 (82%) patients were alive with no evidence of disease, and 1 (6%) was alive with disease. The 3-year OS was 91% and 5-year 80%, and DFS rates were 76% and 76%, respectively. Despite the young age of our patients with mostly high grade tumors, larger tumor size and higher rates of lymph node metastasis, the survival outcomes in our study are favorable in comparison with previously reported series.
Keywords
Adjuvant radiotherapy; metaplastic breast cancer; postoperative radiotherapy; prognosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Chuthapisith S, Warnnissorn M, Amornpinyokiat N, et al (2013). Metaplastic carcinoma of the breast with transformation from adenosquamous carcinoma to osteosarcomatoid and spindle cell morphology. Oncol Lett, 6, 728-32.
2 Dave G, Cosmatos H, Do T, et al (2006). Metaplastic carcinoma of the breast: a retrospective review. Int J Radiat Oncol Biol Phys, 64, 771-5.   DOI   ScienceOn
3 Ellis IO, Cornelisse CJ, Schnitt SJ, et al (2003). Tumors of the breast. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, editors. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press, p. 37-41.
4 Esbah O, Turkoz FP, Turker I, et al (2012). Metaplastic breast carcinoma: Case series and review of the literature. Asian Pac J Cancer Prev, 13, 4645-9.   DOI   ScienceOn
5 Fulford LG, Reis-Filho JS, Ryder K, et al (2007). Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res, 9, 4.
6 Gutman H, Pollock RE, Janjan NA, et al (1995). Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg, 180, 193-9.
7 Al Sayed AD, El Weshi AN, Tulbah AM, et al (2006). Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol, 45, 188-95.   DOI   ScienceOn
8 Bae SY, Lee SK, Koo MY, et al (2011). The prognoses of metaplastic breast cancer patients compared to those of triple negative breast cancer patients. Breast Cancer Res Treat, 126, 471-8.   DOI
9 Wargotz ES, Norris HJ (1989). Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol, 20, 628-35.   DOI   ScienceOn
10 Tseng WH, Martinez SR (2011). Metaplastic breast cancer:to radiate or not to radiate? Ann Surg Oncol, 18, 94-103.   DOI
11 Wargotz ES, Norris HJ (1989). Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer, 64, 1490-9.   DOI
12 Wargotz ES, Deos PH, Norris HJ (1989). Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol, 20, 732-40.   DOI   ScienceOn
13 Wargotz ES, Norris HJ (1989). Metaplastic carcinomas of the breast III: Carcinosarcoma. Cancer, 64, 1490-9.   DOI
14 Wargotz ES, Norris HJ (1990). Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol, 21, 1142-50.   DOI   ScienceOn
15 Wargotz ES, Norris HJ (1990). Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer, 65, 272-6.   DOI
16 Tan PH, Ellis IO (2013). Myoepithelial and epithelialmyoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO classification of tumours of the breast 2012. J Clin Pathol, 66, 465-70.   DOI   ScienceOn
17 Tavassoli FA (1992). Classification of metaplastic carcinomas of the breast. Pathol Annu, 27, 89-119.
18 Rayson D, Adjei AA, Suman VJ, et al (1999). Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol, 10, 413-9.   DOI   ScienceOn
19 Song Y, Liu X, Zhang G, et al (2013). Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World J Surg Oncol, 11, 129.   DOI   ScienceOn
20 Sorlie T (2004). Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer, 40, 2667-75.   DOI   ScienceOn
21 Tavassoli FA, Devilee P (2003). The WHO Classification of Tumors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC press.
22 Toumi Z, Bullen C, Tang AC, et al (2011). Metaplastic breast carcinoma: a case report and systematic review of the literature. Pathol Int, 61, 582-8.   DOI   ScienceOn
23 Lai HW, Tseng LM, Chang TW, et al (2013). The prognostic significance of metaplastic carcinoma of the breast (MCB)- -a case controlled comparison study with infiltrating ductal carcinoma. Breast, 22, 968-73.   DOI   ScienceOn
24 Hennessy BT, Giordano S, Broglio K, et al (2006). Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol, 17, 605-13.   DOI   ScienceOn
25 Hu Q, Chen WX, Zhong SL, et al (2013). Current progress in the treatment of metaplastic breast carcinoma. Asian Pac J Cancer Prev, 14, 6221-5.   DOI   ScienceOn
26 Kurian KM, Al-Nafussi A (2002). Sarcomatoid/metaplastic carcinoma of the breast: aclinicopathological study of 12 cases. Histopathology, 40, 58-64.   DOI   ScienceOn
27 Poggi MM, Danforth DN, Sciuto LC, et al (2003). Eighteenyear results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial. Cancer, 98, 697-702.   DOI   ScienceOn
28 Luini A, Aguilar M, Gatti G, et al (2007). Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European institute of oncology and review of the literature. Breast Cancer Res Treat, 101, 349-53.   DOI   ScienceOn
29 Pezzi CM, Patel-Parekh L, Cole K, et al (2007). Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol, 14, 166-73.
30 Pitts WC, Rojas VA, Gaffey MJ, et al (1991). Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol, 95, 623-32.
31 Rosen PP, Ernsberger D (1987). Low grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma. Am J Surg Pathol, 115, 351-8.
32 Chao TC, Wang CS, Chen SC, et al (1999). Metaplastic carcinomas of the breast. J Surg Oncol, 71, 220-5.   DOI
33 Brenner RJ, Turner RR, Schiller V, et al (1998). Metaplasic carcinoma of the breast: report of three cases. Cancer, 82, 1082-7.   DOI
34 Carey LA, Dees EC, Sawyer L, et al (2007). The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res, 13, 2329-34.   DOI   ScienceOn
35 Carlson RW, Allred DC, Anderson BO, et al (2009). NCCN breast cancer clinical practice guidelines panel. J Natl Compr Cancer Netw, 7, 122-92.